@christin

Interesting FDA updates today 🤔 I wonder how these "speed ups" work against Vinay Prasad who is known to be quite critical of most oncology clinical trial design The FDA says it removed a big barrier that made it hard to use real-world evidence (data from normal care) in some drug/device reviews. This could help get helpful treatments to patients faster. The FDA awarded a “national priority voucher” to speed the path for a myeloma treatment combo after strong Phase 3 results. That can shorten review time once an application is submitted. https://reframedaily.beehiiv.com/p/reframe-daily-er-ultrasound-pain-block-cut-delirium-after-hip-fractures-and-semaglutide-was-tested-a

1 reply

2 recasts

15 reactions